SERVICES

Before any action is taken, we conduct a Molecular Audit. This involves mapping out the "Atomic Structure" of your business. We define the growth narrative by identifying the core molecules that drive value.

• Strategic Alignment: We ensure the company’s long-term vision is chemically stable and attractive to public investors.

• Gap Analysis: We identify "structural fractures"—weaknesses in your current financial or operational setup—that need to be repaired before going public.

In Molecular Finance, the market is an ecosystem of diverse elements. Capital sourcing is about finding the right Catalysts to accelerate growth.

• Strategic Bonding: We don't just find any capital; we find the right quality of capital (PE, VC, or High-Net-Worth individuals) that aligns with your molecular weight.

• Ecosystem Integration: We leverage our partnerships with merchant bankers and underwriters to ensure your company enters the market at the optimal temperature and pressure.

Valuation is the measurement of your company’s intrinsic "Mass." We use data-driven analysis to ensure your price reflects your true potential.

• Molecular Valuation: Moving beyond surface-level multiples, we value the quality of your cash flows and the strength of your governance.

• Audit Transparency: We facilitate rigorous audits to ensure that every "molecule" of financial data is verifiable, transparent, and stable enough to withstand public scrutiny.

This is where we refine the "Chemistry" of your balance sheet. Financial engineering at Arpina Optimus is about rearranging your financial components to create a more robust structure.

• Component Optimization: We re-engineer debt-to-equity ratios and optimize working capital cycles.

• Compliance Synthesis: We ensure all regulatory requirements from SEBI and the exchanges are natively integrated into your corporate DNA, making the transition to a listed entity seamless.

Investor Relations is the art of creating a strong Covalent Bond between your company and its shareholders.

• The Narrative Molecule: We distil your complex operations into a clear, potent equity story that resonates with institutional and retail investors.

• Transparency & Trust: By maintaining a consistent "flow" of information, we ensure that the bond with the market remains strong even after the IPO listing.

Before the launch, the company undergoes a final phase of Molecular Polishing. This ensures the company is "Market Ready."

• Governance Hardening: Strengthening the Board of Directors and internal control systems to act as a protective "shell" for the company.

• Operational Scalability: Ensuring your internal processes are refined enough to handle the increased volume and pressure of being a public entity.